课题基金 / 基金详情

Evaluation of healing process and biocompatibility in artificial organs

Evaluation of healing process and biocompatibility in artificial organs
人工器官愈合过程和生物相容性评价
批准号:
10480248
负责人:
NISHIDA Hiroshi
金额:
$5.89万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B).
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 2000

项目摘要

项目成果

NISHIDA Hiroshi的其他基金

相似基金

相关文献

中文摘要
翻译
综述了旋转血泵的现状和未来前景,从三种不同的辅助模式:辅助身体、植入式和经皮。对于准体外模式,由于成本效益小,离心泵在美国心脏直视手术中的使用已经开始下降。在这个“成本比质量更重要”的时代,为了扭转这一趋势,挽救离心泵最大的市场,进一步降低成本,有意扩大临床应用,开发具有革命性概念的“微创心肺系统”至关重要。对于带氧合器的体外静脉旁路手术,两周的泵就足够了,因为辅助模式本身存在一些本质问题,如左心减压不足以及与氧合器或经皮插管相关的发病率。对于植入式泵来说,旋转血泵确实比脉动泵有许多吸引人的优点,比如体积小、开发和制造成本低、植入过程容易。然而,现在没有人确切地知道无搏动对人类的病理生理影响是什么。在休克后的最初恢复期或有明显脑或肾动脉粥样硬化的患者中,脉动血流可能是强制性的。泵流量的调节可能是另一个需要研究的问题。我们不得不承认,与已经在成千上万的病人身上使用过的各种脉动式植入式泵相比,存在着激烈的竞争。经皮入路可能是旋转血泵最有吸引力,但最容易被忽视的领域。为了弥补主动脉内球囊泵与植入式泵之间的巨大差距,我们应该开发一种安全可靠的经皮左心室辅助泵,这是脉冲泵无法做到的。
英文摘要
The current situation and future perspectives of rotary blood pumps were overviewed from the standpoint of three different assist modes : paracorporeal, implantable, and percutaneous. For the paracorporeal mode, the use of the centrifugal pump in open-heart surgery has begun to decline in the United States because of the small cost benefit. To reverse this trend and save the centrifugal pump for its largest market in this era of "cost matters more than quality, " further cost reduction along with intentional expansion of the clinical applications and the development of a "minimally invasive cardiopulmonary system, " with a revolutionary concept, are important. As for paracorporeal venoarterial bypass with an oxygenator, a two-week pump is sufficient because the assist mode itself has essential problems, such as inadequate left heart decompression and morbidity associated with the oxygenator or percutaneous cannula. For implantable pumps, it is true that rotary blood pumps have many attractive advantages over pulsatile pumps, such as compactness, lower developmental and manufacturing costs and ease of the implantation procedure. However, no one is quite sure what the pathophysiological effects of non-pulsatile now are on humans. Pulsatile flow may be mandatory during the initial recovery period from shock or in patients with significant atherosclerosis of the brain or kidneys. The regulation of the pump flow may be another point to be investigated. We have to admit there is strong competition with the various pulsatile implantable pumps that have already been used in thousands of patients. The percutaneous approach may be the most attractive, yet most neglected, field for rotary blood pumps. To cover the wide gap between the intraaortic balloon pump and implantable pumps, we should develop a safe and reliable percutaneous left ventricular assist pump, which is impossible with a pulsatile pump.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
Nishida H, Aomi S, Tomizawa Y, Endo M, Koyanagi H, Nojiri C, Oshiyama H, Kido T, Yokoyama K: "Comparative study of biocompatibility between the open circuit and closed circuit in cardiopulmonary bypass"Artif Organs. 23. 547 (1999)
Nishida H、Aomi S、Tomizawa Y、Endo M、Koyanagi H、Nojiri C、Oshiyama H、Kido T、Yokoyama K:“体外循环中开路和闭路生物相容性的比较研究”Artif Organs。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
冨澤康子 ほか: "人工臓器とトラッキング;医用材料植え込み患者追跡の実際"人工臓器. 29. 496-499 (2000)
Yasuko Tomizawa 等人:“人工器官和跟踪;植入医疗材料的患者的跟踪”人工器官。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tomizawa Y et al: "Evaluation of small caliber vascular prostheses implanted in small children; activated angiogenesis and accelerated calcification" ASAIO J. 44. M496-M500 (1998)
Tomizawa Y 等人:“小口径血管假体植入儿童体内的评估;激活血管生成和加速钙化”ASAIO J. 44. M496-M500 (1998)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
冨澤康子: "細胞と組織移植によるバイオ人工血管" 人工臓器. 27. 708-714 (1998)
Yasuko Tomizawa:“使用细胞和组织移植的生物人工血管”《人工器官》27. 708-714 (1998)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Application of eye tracking approach to safe behavior analysis in medical domain
  • 批准号:
    23651158
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.58万
  • 财政年份:
    2011
  • 负责人:
    NISHIDA Hiroshi
  • 依托单位:
Cell transplantation for an unloaded failing heart aiming at the improvement of the SERCA2a level in myocytes
  • 批准号:
    18390353
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $10.69万
  • 财政年份:
    2006
  • 负责人:
    NISHIDA Hiroshi
  • 依托单位:
Evaluation of cardiac function and anatomy of a knockout mouse with cardiac failure
  • 批准号:
    15390385
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $9.66万
  • 财政年份:
    2003
  • 负责人:
    NISHIDA Hiroshi
  • 依托单位:
DEVELOPMENT OF AN OXYGENATOR WITH BUILT-IN HEMOCONCENTRATOR
  • 批准号:
    05671140
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 资助金额:
    $1.34万
  • 财政年份:
    1993
  • 负责人:
    NISHIDA Hiroshi
  • 依托单位:
海外基金